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While immunosuppressive regimens improve the overall survival of renal transplant recipients, they also contribute
to the long-term complications of post-transplant malignancies. Chronic immune suppression in renal transplant
recipients (RTR) increases the risk of viral-associated cancers. In male RTR, human papillomavirus (HPV) is implicated
in the development of penile, anal, oropharyngeal, and non-melanoma skin carcinomas. Despite the significance of
this virus in RTR, there is an overall deficiency in the understanding of the natural history of HPV infection in male
RTR. In the next 20 years, it is believed that cancers will be the leading cause of death in kidney transplant
recipients. HPV-associated carcinomas are of particular interest since they are sexually transmitted and in theory
may be preventable diseases. This commentary highlights some of the progress made in understanding how HPV is
transmitted amongst couples in the general population. It also summarizes the current knowledge of HPV infection
in male RTR and describes the deficiencies in published medical literature.
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Renal transplant recipients (RTR) have an increased inci-
dence of human papillomavirus (HPV)-related malig-
nancies, however, studies on the natural history of HPV
infection are lacking especially in male RTR. While im-
munosuppressive regimens improve the overall survival
of renal transplant recipients, they also contribute to the
long-term complications of post-transplant malignancies
[1-6]. In males, oncogenic HPV types are associated with
penile, anal, oropharyngeal, and non-melanoma skin
cancers [1]. Of significance for male RTRs is that these
HPV-associated cancers are also known to be signifi-
cantly increased post kidney transplantation [6-9]. On-
going research is being done to examine the molecular
mechanism and risk factors associated for HPV carcino-
genesis, since epidemiologic studies clearly show an
increased risk of HPV-associated cancers post trans-
plantation. Despite this fact, there is limited knowledge
on the immunologic alterations post-transplantation that
make RTR susceptible to HPV carcinogenesis in males.* Correspondence: mario_md@yahoo.com
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reproduction in any medium, provided the orUnderstanding how RTR acquire HPV infection at spe-
cific organ sites is important since it may have implica-
tions for prevention strategies via safe sex practices,
screening, and lifestyle modifications post kidney trans-
plant. While all solid organ transplant patients are at risk
for HPV-associated malignancies [10] because they share
many commonalities, there were differences with regard
to patient demographics, co-morbidities and more im-
portantly immunosuppressive regimens used. As a re-
sult, examining HPV infection post transplantation
requires a comprehensive investigation specific to each
individual organ transplant group to better understand
the natural history, pathogenesis, and the immunologic
microenvironment that makes these patients susceptible
to HPV carcinogenesis. Specifically targeting research in
the renal transplant population is important because as
it is known they are the most common transplantation
group. In 2010, out of 28,663 organ transplants that
were performed in the US, 16,899 patients received kid-
ney transplants compared to 6,291 liver transplants,
2,333 heart transplants, and 1,770 lung transplants [11].
In addition, after any kind of solid organ transplant,
there is an increase in chronic renal failure which will
eventually require a renal transplant or hemodialysis.
Centers of excellence that care for and monitor largeLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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this effort and conduct much needed research in under-
standing the biology of HPV infection and the associated
cancers in males RTR.
Our group attempted to establish the prevalence of
genital HPV infection in males post kidney transplant-
ation by conducting a systematic review of the published
medical literature in the Medline database. Our inclu-
sion criteria consisted of studies that examined HPV by
in-situ hybridization, PCR, or histopathology. We
excluded case reports and studies that evaluated men
that had sex with men or anal HPV infection because
while it is important to look at all groups of men in the
RTR population, heterosexual men have been extremely
under-represented in studies, yet they make up the ma-
jority of male RTR. Through our search, only 19 citations
were identified examining anogenital infection in male
RTR; however, they were excluded based on our criteria.
To our surprise, there are no published studies that have
been done reporting the prevalence of genital HPV in
heterosexual male RTR, despite the fact that thousands
of men have undergone kidney transplantation.
In addition to urogenital malignancies in RTR, HPV
infection has been implicated by some investigators to
be associated with having an increased risk of squamous
cell carcinoma (SCC) of the skin [11-13]. Unlike muco-
sal HPV infections in which transforming oncogenes
HPV E6 and E7 can causes cancer when viral replication
is disrupted, some cutaneous HPV infections are sus-
pected to induce skin keratinocyte transformation via
different mechanisms. Human paillomaviruses are cate-
gorized in five genera based on DNA sequences. The α
group is the most common and includes high-risk HPV
(types 16 and 18). The β-HPV genus which produce cu-
taneous infection have been reported to attenuate the
harmful effects of sun exposure [11,12]. In a study by
Wallace et al. [11], investigators show that β-HPV E6
gene expression along with UVB promoted p300 degrad-
ation, this ultimately resulted in increased UVB-induced
DNA damage, therefore increased risk of cancer. Fur-
thermore, in another study by Proby et al. [14], investi-
gators reported on 210 organ transplant recipients with
previous SCC and 394 controls without skin cancer. The
presence of 25 beta HPV types was examined for viral
DNA and serum antibodies response for the 15 most
prevalent beta HPV types. In this study authors found a
significant association between SCC when patients had a
concordant detection of both antibodies and DNA for at
least one beta HPV type present. Though some good
evidence exists and has been reviewed [14], studies have
not always been consistent in establishing HPV as a
cause of SCC of the skin in RTR. Cutaneous HPV infec-
tion in the immunocompetent and immunocomprom-
ised host both have a high prevalence of at least 90%, yetorgan transplant recipients have a 100-fold increase in
SCC [1]. Clearly, post transplantation skin carcinogen-
esis is increased for reasons unknown. Solar as well as
environmental factors contribute; cutaneous HPV infec-
tion may be a co-factor in some patients [15,16].
When looking at screening tests for HPV in men, the
options are limited. Unlike women where established
commercial tests are available, HPV testing in men in
the clinical setting is not done and published reports in
the general population use only the research methods.
This is another factor which has limited research for
studying HPV infection in men. In women, a localized
sample of cervical mucosa is easily collected to test for
HPV DNA, while in men the cornified epithelium of the
penis and scrotum does not always provide a reliable
collection of relevant cells [17]. Therefore, the variable
prevalence rates that have been reported in studies that
examine HPV infection in men in the general population
may be due to inaccurate testing estimates and not true
infection rates among populations studied. Furthermore,
men are known to harbor HPV infection in multiple sites,
including the perineum. Therefore, determining that a male
patient is HPV-negative is more complex than in a female
patient. Diagnostic tests and procedures need to be estab-
lished to standardize the collection of samples and detection
of HPV DNA in men. This would improve research studies
that investigate the natural history of this virus in men.
In the next 20 years, it is believed that cancer will be the
leading cause of death post transplantation [9]. HPV-
associated cancers of the urogenital tract are of particular
interest, since they are sexually transmitted and in theory
may be preventable diseases. It is therefore important to
look at potentially modifiable risk factors to reduce cancer
risk. Sexual practices post transplant can increase the risk
of HPV exposure. To date, little is known about HPV post
transplantation in heterosexual men. Transplantation spe-
cialists and physicians that care for these patients have the
opportunity to lead an effort to conduct comprehensive re-
search to study HPV infection. Meanwhile, physician
awareness of this disease can lead to better doctor-patient
communication to discuss sexual behavior and choices
post-kidney transplantation. Counseling patients on ‘safe’
sex practices (latex condom use) or abstinence, mutual sex-
ual monogamy, and discussing patient and partner’s sexual
history post transplantation may significantly reduce the in-
cidence of HPV-related malignancies. This is an approach
for cancer risk reduction that is practical, cost-effective, and
achievable.
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